Oriental Carbon and Chemicals (OCCL) Q4 19/20 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 19/20 earnings summary
2 Nov, 2026Executive summary
FY20 was affected by economic slowdown and COVID-19 disruption; operating revenue fell 11% YoY and Insoluble Sulphur sales declined 9%, while margins remained stable.
Operations restarted in phases after lockdowns; management expected a slow demand recovery and forecast FY21 turnover down 25–30% and PBT down ~50% YoY.
Financial highlights
Standalone operating revenue was ₹34,347.90 lakh vs ₹38,763.86 lakh; total revenue was ₹35,304.48 lakh vs ₹39,703.98 lakh.
Standalone EBITDA was ₹10,851 lakh vs ₹12,941 lakh; PBT was ₹7,930 lakh vs ₹10,257.48 lakh; PAT was ₹7,150.55 lakh vs ₹7,374.14 lakh.
Standalone EPS was ₹71.58 vs ₹72.09; consolidated revenue was ₹38,679.33 lakh vs ₹43,200.77 lakh and consolidated PAT was ₹7,476.85 lakh vs ₹7,652.08 lakh.
Net worth increased to ₹46,797.96 lakh from ₹41,353.48 lakh; operating cash flow was ₹10,778.61 lakh vs ₹8,851.15 lakh.
Outlook and guidance
FY21 turnover was expected to decline 25–30% and PBT-level profitability about 50% vs FY20; demand recovery was expected to be gradual, with potential revival later in the year if conditions improved.
Dharuhera Phase 1 expansion commissioning was delayed to Q1 FY22 from Q3 FY21 due to suspended civil work and labor shortages; no significant cost impact was anticipated at the time.
Demand was reported to be slowly returning, with expectations for better performance each quarter of FY21.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12